Rex Fang & Innovation Equity Premium Income ETF vs Kimberly Clark Corp — how do they compare? Rex Fang & Innovation Equity Premium Income ETF trades at $41.58, while Kimberly Clark Corp trades at $109.04 (market cap $35.36B). The key difference: Kimberly Clark Corp pays a 4.81% dividend while Rex Fang & Innovation Equity Premium Income ETF pays none. Which is the better fit depends on your goals.
| FEPI | KMB | |
|---|---|---|
Sector | Income / Options Overlay | Consumer Staples |
52-Week High | $49.54 | $136.77 |
52-Week Low | $38.13 | $93.05 |
Market Cap | — | $35.36B |
Enterprise Value | — | $41.90B |
Dividend Yield | — | 4.81% |
Signals from Pluang's Aura AI — not financial advice
FEPI trades at $41.76, down 1.6% today, with a bearish technical signal from moving averages. The ETF generates high income through weekly covered call distributions, recently transitioning to weekly payouts. Recent dividends show consistent payments around $0.20-$0.22 per share, with one larger $0.90 distribution in April 2026. The concentrated portfolio of AI and mega-cap tech names provides QQQ-like exposure but with capped upside from call writing.
The outlook remains cautious due to NAV erosion risks from the covered call strategy limiting participation in rallies. While the 25% yield attracts income seekers, total returns have lagged broader tech indices. Key risks include high portfolio concentration and market volatility impacting premium income generation. Analyst views are mixed, balancing high yield against structural limitations.
Kimberly-Clark (KMB) trades at $106.82, down 3.05% on the day, near the analyst low target of $106.00. The stock shows a bullish technical signal with RSI at 24.78 indicating potential oversold conditions, while recent quarterly EPS beats and a 4.5% dividend yield highlight fundamental strength. The company's pending Kenvue acquisition and innovation-driven growth strategy are key developments, though revenue declined to $16.45B in 2025 from $20.1B in 2024.
KMB offers a stable income play with consistent dividend payments, but investors face risks from high payout ratios and competitive pressures. Analyst consensus is mixed with 32% buy ratings, suggesting cautious optimism. Near-term performance hinges on Q2 2026 earnings due August 4, 2026, with margins under scrutiny amid input cost inflation.
Trailing returns across standard periods
FEPI provides exposure to top innovation stocks while generating monthly income. It uses a covered call strategy on high-volatility tech stocks to capture option premiums for investors.
Read more on FEPI →With around half of sales from personal care and another third from tissue products, Kimberly-Clark sits as a leading manufacturer of tissue and hygiene realm. Its brand mix includes Huggies, Pull-Ups, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates K-C Professional, which partners with businesses to provide safety and sanitary products for the workplace. Kimberly-Clark generates just over of half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.
Read more on KMB →